NO994053D0 - Preparater for behandlingen av metabolsk syndrom inneholdende humant veksthormon i kombinasjon med en kortisolsyntese-inhibitor - Google Patents

Preparater for behandlingen av metabolsk syndrom inneholdende humant veksthormon i kombinasjon med en kortisolsyntese-inhibitor

Info

Publication number
NO994053D0
NO994053D0 NO994053A NO994053A NO994053D0 NO 994053 D0 NO994053 D0 NO 994053D0 NO 994053 A NO994053 A NO 994053A NO 994053 A NO994053 A NO 994053A NO 994053 D0 NO994053 D0 NO 994053D0
Authority
NO
Norway
Prior art keywords
preparations
treatment
combination
growth hormone
metabolic syndrome
Prior art date
Application number
NO994053A
Other languages
English (en)
Other versions
NO994053L (no
Inventor
Per Morin
Original Assignee
Cortendo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortendo Ab filed Critical Cortendo Ab
Publication of NO994053D0 publication Critical patent/NO994053D0/no
Publication of NO994053L publication Critical patent/NO994053L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO994053A 1997-02-24 1999-08-23 Preparater for behandlingen av metabolsk syndrom inneholdende humant veksthormon i kombinasjon med en kortisolsyntese-inhibitor NO994053L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700642A SE9700642D0 (sv) 1997-02-24 1997-02-24 Medel och sätt för förebyggande och behandling av det metabola syndromet
PCT/GB1998/000574 WO1998036770A1 (en) 1997-02-24 1998-02-24 Preparations for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor

Publications (2)

Publication Number Publication Date
NO994053D0 true NO994053D0 (no) 1999-08-23
NO994053L NO994053L (no) 1999-09-24

Family

ID=20405901

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994053A NO994053L (no) 1997-02-24 1999-08-23 Preparater for behandlingen av metabolsk syndrom inneholdende humant veksthormon i kombinasjon med en kortisolsyntese-inhibitor

Country Status (12)

Country Link
US (1) US6274582B1 (no)
EP (1) EP1030682A1 (no)
JP (1) JP2001513082A (no)
KR (1) KR20000075626A (no)
CN (1) CN1178696C (no)
AU (1) AU743277B2 (no)
CA (1) CA2282467A1 (no)
NO (1) NO994053L (no)
NZ (1) NZ337123A (no)
RU (1) RU2198679C2 (no)
SE (1) SE9700642D0 (no)
WO (1) WO1998036770A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642236B1 (en) * 1998-12-14 2003-11-04 Cortendo Ab Methods for prophylactic treatment of cardiovascular disease with inhibitor of cortisol synthesis
IL145524A0 (en) * 1999-04-01 2002-06-30 Akzo Nobel Nv Formulation comprising testosterone undecanoate and castor oil
AU2004200545B2 (en) * 1999-08-18 2007-05-17 Microdose Therapeutx, Inc. Metering and packaging of controlled release medication
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
GB0001449D0 (en) * 2000-01-21 2000-03-08 Cortendo Ab Compositions
SE0001899D0 (sv) 2000-05-22 2000-05-22 Pharmacia & Upjohn Ab New compounds
US7094792B2 (en) 2001-11-22 2006-08-22 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
US6967194B1 (en) * 2002-09-18 2005-11-22 Susan Matsuo Bio-identical hormones and method of use
US7662404B2 (en) * 2002-10-31 2010-02-16 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
IL152574A (en) * 2002-10-31 2009-09-22 Transpharma Medical Ltd A system for passing through the skin of dry items or dried medicines
US8133505B2 (en) * 2002-10-31 2012-03-13 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
US7383084B2 (en) * 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
JO2505B1 (en) * 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
US20050031718A1 (en) * 2003-04-10 2005-02-10 Pharmanex, Llc Sea Buckthorn compositions and associated methods
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
DE102004034640A1 (de) 2004-07-16 2006-02-16 Institut für Molekular- und Systemmedizin Verfahren zur systemischen Biokorrektur eines Organismus
ATE528005T1 (de) * 2005-01-10 2011-10-15 Cortendo Ab Publ 2s,4r ketoconazol zur behandlung von diabetes, metabolischem syndrom und anderen erkrankungen
KR100705981B1 (ko) * 2005-10-12 2007-04-10 주식회사 리제론 인간 성장호르몬을 포함하는 탈모방지 또는 발모촉진용조성물
ZA200902127B (en) 2006-10-02 2010-07-28 Cortendo Invest Ab Ketoconazole enantiomer in humans
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
CA2742964C (en) 2008-11-07 2020-07-07 University Of Sheffield Medicament and method of diagnosis
TWI589313B (zh) 2010-01-05 2017-07-01 麥可朵斯斯若波特公司 醫藥遞送封裝及吸入器
DK2524039T3 (en) * 2010-01-11 2018-03-12 Curna Inc TREATMENT OF GENDER HORMON-BINDING GLOBULIN (SHBG) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENCE TRANSCRIPTS TO SHBG
ES2749008T3 (es) 2014-06-17 2020-03-18 Merck Sharp & Dohme Formulaciones estables de undecanoato de testosterona

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE244009T1 (de) * 1994-08-09 2003-07-15 Metabolic Syndrome I Gbg Ab Verwendung von ketoconazol und verwandten substanzen in medikamenten für die behandlung des typ ii-diabetes

Also Published As

Publication number Publication date
NZ337123A (en) 2005-05-27
WO1998036770A1 (en) 1998-08-27
AU6302398A (en) 1998-09-09
CA2282467A1 (en) 1998-08-27
KR20000075626A (ko) 2000-12-26
CN1248170A (zh) 2000-03-22
NO994053L (no) 1999-09-24
JP2001513082A (ja) 2001-08-28
US6274582B1 (en) 2001-08-14
SE9700642D0 (sv) 1997-02-24
EP1030682A1 (en) 2000-08-30
AU743277B2 (en) 2002-01-24
RU2198679C2 (ru) 2003-02-20
CN1178696C (zh) 2004-12-08

Similar Documents

Publication Publication Date Title
NO994053L (no) Preparater for behandlingen av metabolsk syndrom inneholdende humant veksthormon i kombinasjon med en kortisolsyntese-inhibitor
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
AU3683800A (en) Device for the therapeutic and cosmetic photo-processing of biological tissues and method for using the same
HUP0202862A3 (en) Pharmaceutical composition containing novel combination of loteprednol and antihistamines
AU1897199A (en) Use of formoterol in medicament for inflammation/allergy in upper airways
DE69827357D1 (de) Menschliches Wachstumshormon enthaltende pharmazeutische Zusammensetzung
DK0589086T3 (da) Tandlæge-patientstol
EE04043B1 (et) H+,K+-ATPaasi inhibiitori ja glükokortikoidide kasutamine ravimvormi valmistamiseks
DE69312501D1 (de) Zahnseidenabgabevorrichtung und Applikator
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
FI973185A (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
DE69713505D1 (de) Arzneimittel enthaltend mizolastin mit verzögerter wirkstoffabgabe
ATE256465T1 (de) Orale arzneimittel zubereitung von piperdinoalkanole in gelöster form
ID24940A (id) Pemakaian ketolida-ketolida untuk pencegahan komplikasi trombotik arteri mengenai aterosklerosis
KR950700737A (ko) 기도 염증 및 기도 과잉반응의 치료약품(Medicament for the treatment of airways inflammation and airways hyperresponsiveness)
IL116532A0 (en) 1-oxo-2-(phenylsulphonylamino) pentylpiperdine derivatives their preparation and their therapeutic application
AU9034291A (en) Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance
FI973392A0 (fi) Fluorihiilinesteiden käyttö kiihdyttämään keuhko- ja muiden kudosten kasvua
NO953002D0 (no) Anvendelse av eliprodil og enantiomerer derav for fremstilling av medisinske preparater
NO974651D0 (no) Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose
ITMI920261V0 (it) Vaporizzatore per scopi medicali e cosmetici
AU1447892A (en) Pharmaceutical preparations for the therapy of tumors containing colchicine as the active principle and methods for the use of the same
DE69732974D1 (de) 5-phenyl-3-pyridazinon-derivate und diese enthaltende arzneimittelzubereitungen
AU9166598A (en) Use of sulphonanilide derivatives to obtain a medicine for treating retrograde ejaculation or aspermia

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application